NO20053780L - Alfa-aminamidderivater nyttig som antimigrenemidler - Google Patents

Alfa-aminamidderivater nyttig som antimigrenemidler

Info

Publication number
NO20053780L
NO20053780L NO20053780A NO20053780A NO20053780L NO 20053780 L NO20053780 L NO 20053780L NO 20053780 A NO20053780 A NO 20053780A NO 20053780 A NO20053780 A NO 20053780A NO 20053780 L NO20053780 L NO 20053780L
Authority
NO
Norway
Prior art keywords
alpha
derivatives useful
aminamide
migraine agents
migraine
Prior art date
Application number
NO20053780A
Other languages
English (en)
Other versions
NO333610B1 (no
NO20053780D0 (no
Inventor
Patricia Salvati
Piero Melloni
Marcello Calabresi
Luciano Dho
Orietta Veneroni
Original Assignee
Newron Pharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharm Spa filed Critical Newron Pharm Spa
Publication of NO20053780D0 publication Critical patent/NO20053780D0/no
Publication of NO20053780L publication Critical patent/NO20053780L/no
Publication of NO333610B1 publication Critical patent/NO333610B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

a-aminamidderivater er nyttige som antimigrenemidler, spesielt for behandling av hodepinetilstander slik som migrene, klosterhodepine eller annen alvorlig hodepine angitt. Antimigrenemidlene ifølge oppfinnelsen er i stand til å redusere eller enda stoppe smerten som kommer fra slike tilstander uten praktisk talt noen bivirkninger.
NO20053780A 2003-01-16 2005-08-09 Anvendelse av alfa-aminamidderivater ved fremstilling av et medikament for behandling av hodepinetilstander NO333610B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03000921A EP1438956A1 (en) 2003-01-16 2003-01-16 Alpha-aminoamide derivatives useful as antimigraine agents
PCT/EP2003/012889 WO2004062655A1 (en) 2003-01-16 2003-11-18 Alpha-aminoamide derivatives useful as antimigraine agents

Publications (3)

Publication Number Publication Date
NO20053780D0 NO20053780D0 (no) 2005-08-09
NO20053780L true NO20053780L (no) 2005-10-13
NO333610B1 NO333610B1 (no) 2013-07-22

Family

ID=32524140

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053780A NO333610B1 (no) 2003-01-16 2005-08-09 Anvendelse av alfa-aminamidderivater ved fremstilling av et medikament for behandling av hodepinetilstander

Country Status (21)

Country Link
US (2) US7709523B2 (no)
EP (2) EP1438956A1 (no)
JP (1) JP4885455B2 (no)
KR (1) KR101049694B1 (no)
CN (1) CN100418517C (no)
AT (1) ATE380026T1 (no)
AU (1) AU2003279399B8 (no)
BR (1) BRPI0317795B8 (no)
CA (1) CA2510514C (no)
CY (1) CY1107274T1 (no)
DE (1) DE60317935T2 (no)
DK (1) DK1585510T3 (no)
ES (1) ES2295658T3 (no)
HK (1) HK1086487A1 (no)
MX (1) MXPA05007339A (no)
NO (1) NO333610B1 (no)
NZ (1) NZ541117A (no)
PT (1) PT1585510E (no)
RU (1) RU2336077C2 (no)
SI (1) SI1585510T1 (no)
WO (1) WO2004062655A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
JP4350508B2 (ja) * 2001-09-03 2009-10-21 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途
KR101233711B1 (ko) * 2003-08-25 2013-02-18 뉴론 파마슈티칼즈 에스. 피. 에이. 항염증제로서 유용한 알파-아미노아미드 유도체
NZ553970A (en) * 2004-09-10 2010-01-29 Newron Pharm Spa Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators
KR101380137B1 (ko) 2005-12-22 2014-04-11 뉴론 파마슈티칼즈 에스. 피. 에이. 칼슘 및/또는 나트륨 채널 조절제로서 2-페닐에틸아미노유도체
PL2474521T3 (pl) 2006-06-19 2017-01-31 Newron Pharmaceuticals S.P.A. 2-[4-(3- i 2-fluorobenzyloksy)benzyIoamino]propanoamidy o wysokim stopniu czystości do zastosowania jako leki i preparaty farmaceutyczne je zawierające
FR2903985B1 (fr) 2006-07-24 2008-09-05 Sanofi Aventis Sa Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
NO2155663T3 (no) 2007-06-15 2018-04-28
KR101709498B1 (ko) 2007-12-11 2017-02-23 뉴론 파마슈티칼즈 에스. 피. 에이. 고순도의 ２­［４­（３­ 또는 ２­플루오로벤질옥시）벤질아미노］프로판아미드의 제조방법
EP2314569A1 (en) 2009-10-22 2011-04-27 Merck Patent GmbH Novel polymorphic forms of (S)-2-[4-(3-Fluoro-benzyloxy)-benzylamino]-propionamide mesylate salt and processes of manufacturing thereof
CN102858330B (zh) 2010-04-27 2015-07-22 纽朗制药有限公司 用于制备拉非酰胺甲磺酸盐或其r-对映异构体的方法
KR101705718B1 (ko) * 2013-12-30 2017-02-14 이화여자대학교 산학협력단 신규한 아미드 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 통증의 예방 또는 치료용 약학적 조성물
CN107522654B (zh) * 2016-06-21 2020-09-01 中国人民解放军军事医学科学院毒物药物研究所 新的α-氨基酰胺衍生物及其医药用途
CN112041296B (zh) * 2018-04-28 2023-12-29 上海璃道医药科技有限公司 包含苯并含氧脂肪环结构的氨基乙酰胺类化合物及其用途
CN112716927B (zh) * 2020-10-12 2022-10-14 复旦大学 α-氨基酰胺类化合物及其制备方法与应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658967A (en) 1966-06-23 1972-04-25 Ici Ltd Carboxylic acid derivatives for lowering the concentration of triglycerides in the blood
GB1140748A (en) 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
CH480308A (de) 1966-08-11 1969-10-31 Ciba Geigy Verfahren zur Herstellung von Thiosemicarbazid-Verbindungen
US4049663A (en) 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
US4311853A (en) 1979-02-06 1982-01-19 The Radiochemical Centre Limited Selenium derivatives of thyroxine and tri-iodothyronine
DE3050800C2 (no) 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
US4267354A (en) 1979-04-25 1981-05-12 E. R. Squibb & Sons, Inc. Substituted amides having antiinflammatory activity and intermediates
ZA805476B (en) 1979-09-26 1981-11-25 Robins Co Inc A H 2-amino-3-benzoyl-phenylacetamides and cyclic homologues
FR2480747A1 (fr) 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
EP0144853B1 (en) 1983-11-21 1990-09-26 Fujisawa Pharmaceutical Co., Ltd. Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
US4725619A (en) 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
GB8714901D0 (en) 1986-07-23 1987-07-29 Ici Plc Amide derivatives
GB2216515A (en) 1988-03-04 1989-10-11 Nippon Shinyaku Co Ltd Acylphenol derivatives
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
DE3928488A1 (de) 1989-08-29 1991-03-07 Standard Elektrik Lorenz Ag Interferometrisches messsystem
DE69224861T2 (de) 1991-07-30 1998-08-06 Korea Res Inst Chem Tech Neue Phenylacetamidderivate und Verfahren zu ihrer Herstellung
US5498610A (en) 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
GB9306899D0 (en) 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
US5475007A (en) 1993-05-28 1995-12-12 The Regents Of The University Of California 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof
US5482964A (en) 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
KR0147963B1 (ko) 1995-01-10 1998-08-17 강박광 엔-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
US5849737A (en) 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
GB9515411D0 (en) 1995-07-27 1995-09-27 Pharmacia Spa N-(4-substituted-benzyl)-2-aminolactam derivatives
US5688830A (en) 1996-01-25 1997-11-18 Syntex (U.S.A.) Inc. Treatment of neuropathic pain
JP4160136B2 (ja) * 1996-08-29 2008-10-01 武田薬品工業株式会社 縮合環状エーテル類、その製造法および剤
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
GB9625795D0 (en) 1996-12-12 1997-01-29 Smithkline Beecham Plc Novel treatment
GB9706730D0 (en) 1997-04-03 1997-05-21 Pharmacia & Upjohn Spa 2-[(3-substituted)-5-Isoxazolymethylaminojalkanamid derivatives
JP2001526648A (ja) 1997-04-22 2001-12-18 コセンシス・インコーポレイテッド 炭素環及びヘテロ環で置換されたセミカルバゾン及びチオセミカルバゾン、及びその使用
DE69842004D1 (de) 1997-11-21 2010-12-30 Purdue Neuroscience Co Substituierte 2-aminoacetamide und anwendung davon
GB9727521D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Substituted 2-benzylamino-2-phenyl-acetamide compounds
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
JP2002511387A (ja) * 1998-02-04 2002-04-16 ユーロ−セルティック エス． ア． 置換セミカルバジドおよびその使用
KR20010103583A (ko) * 1998-10-19 2001-11-23 다니구치 미즈오 진통제
JP2000191533A (ja) * 1998-10-19 2000-07-11 Eisai Co Ltd 鎮痛剤
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
WO2000057877A1 (en) * 1999-03-26 2000-10-05 Euro-Celtique S.A. Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
JP4350508B2 (ja) * 2001-09-03 2009-10-21 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
EP1588704A1 (en) 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
NZ553970A (en) 2004-09-10 2010-01-29 Newron Pharm Spa Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators

Also Published As

Publication number Publication date
KR20050094852A (ko) 2005-09-28
US20100267835A1 (en) 2010-10-21
DE60317935T2 (de) 2008-11-27
CA2510514C (en) 2011-07-26
JP4885455B2 (ja) 2012-02-29
HK1086487A1 (en) 2006-09-22
EP1585510B1 (en) 2007-12-05
CY1107274T1 (el) 2012-11-21
BRPI0317795B8 (pt) 2021-05-25
CA2510514A1 (en) 2004-07-29
CN1738611A (zh) 2006-02-22
PT1585510E (pt) 2008-02-28
WO2004062655A1 (en) 2004-07-29
NZ541117A (en) 2008-02-29
KR101049694B1 (ko) 2011-07-19
US7709523B2 (en) 2010-05-04
AU2003279399A1 (en) 2004-08-10
AU2003279399B8 (en) 2009-01-29
BRPI0317795B1 (pt) 2019-04-02
AU2003279399B2 (en) 2008-11-27
SI1585510T1 (sl) 2008-04-30
JP2006514060A (ja) 2006-04-27
CN100418517C (zh) 2008-09-17
RU2336077C2 (ru) 2008-10-20
ES2295658T3 (es) 2008-04-16
BR0317795A (pt) 2005-11-22
ATE380026T1 (de) 2007-12-15
DK1585510T3 (da) 2008-02-25
EP1438956A1 (en) 2004-07-21
DE60317935D1 (de) 2008-01-17
EP1585510A1 (en) 2005-10-19
US20060079570A1 (en) 2006-04-13
NO333610B1 (no) 2013-07-22
RU2005125919A (ru) 2006-01-10
NO20053780D0 (no) 2005-08-09
MXPA05007339A (es) 2005-09-30

Similar Documents

Publication Publication Date Title
NO20053780L (no) Alfa-aminamidderivater nyttig som antimigrenemidler
SE0203713D0 (sv) Novel compounds
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
SE0303180D0 (sv) Novel compounds
TW200407305A (en) Novel compounds
NO20082136L (no) 1,5-substituerte indol-2-yl-amidderivater
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20092711L (no) Metoder for anvendelse av cyclopaminanaloger
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
DE602004013563D1 (de) Rantagonisten
IS8505A (is) (S)-2-N-própýlamínó-5-hýdroxýetralín sem D3-gerandefni
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
NO20082174L (no) 3,5-disubstituerte fenylpiperidiner som modulatorer av dopamin-neurotransmisjon
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
TW200738651A (en) Cyclohexyl sulfonamide derivatives
NO20082214L (no) 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
IL161047A0 (en) Pyrazole derivatives for increasing endogenous testosterone levels
MX2022005084A (es) Formas sólidas de un modulador del receptor s1p a.
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
CY1112194T1 (el) Μεθοδοι για ρυθμιση φωτοτοξικοτητας
NO20074562L (no) Fremgangsmater for behandling av Parkinsons sykdom
ATE289510T1 (de) Sulfonylpyridazinone derivate zur behandlung von ischämischem gewebeschaden
SE0301798D0 (sv) New use IV

Legal Events

Date Code Title Description
MK1K Patent expired